Neoadjuvant therapy—using treatments such as chemotherapy, hormone therapy or radiation to shrink a tumor or treat unseen metastases before surgery—can improve outcomes for some patients.
by Sharon Tregaskis
Amid the ongoing pandemic, Cancer Today continues to cover cancer research and treatment while also reporting on the many ways COVID-19 has impacted people with cancer.
Survivorship care plans can prepare cancer patients to get the best medical care and maintain their quality of life following treatment.
A trial of the targeted therapy Tagrisso (osimertinib) for early-stage lung cancer finds that patients who take it go longer without having a cancer recurrence. Whether that should change clinical practice is under discussion.
A new version of the American Cancer Society’s cervical cancer screening guideline says screening can start at a later age and highlights human papillomavirus testing as the preferred method.
In an interview, Carl June discusses CAR-T cell therapy, as well as his own experience with COVID-19.
A meeting on lymphoma covered diverse topics, ranging from immunotherapeutic strategies to advances in single-cell analyses to health disparities.
The inaugural Cancer Disparities Progress Report highlights the urgent need to reduce cancer health disparities and achieve health equity for all people.
Handle With Care
donate to the AACR
The AACR Cancer Progress Report 2019, which is published annually by the American Association for Cancer Research, tracks recent developments that impact cancer care. Click “Progress Report” below to find out more.